Expanded Proteomic Survey of the Human Parasite Leishmania major Focusing on Changes in Null Mutants of the Golgi GDP-Mannose/Fucose/Arabinopyranose Transporter LPG2 and of the Mitochondrial Fucosyltransferase FUT1

Gloria Polanco, Nichollas E. Scott, Lon F. Lye, Stephen M. Beverley and Sumiti Vinayak

Microbiol Spectr, 2022, 10
DOI: 10.1128/spectrum.03052-22

Integrated N-glycoproteomics Analysis of Human Saliva for Lung Cancer

Sha Liu, Huiyu Wang, Xiaoteng Jiang, Yin Ji, Zeyuan Wang, Yan Zhang, Peng Wang and Hua Xiao

J. Proteome Res., 2022, 21, 1589
DOI: 10.1021/acs.jproteome.1c00701

Effect of DODAB Nano-Sized Cationic Bilayer Fragments against Leishmania amazonensis

Thalita C. S. Ferreira, Ismael P. Sauter, Lina Borda-Samper, Enyd Bentivoglio, Jarina P. DaMata, Noemi N. Taniwaki, Patrício R. Orrego, Jorge E. Araya, Nilton Lincopan and Mauro Cortez

Molecules, 2020, 25, 5741
DOI: 10.3390/molecules25235741

How can proteomics overhaul our understanding of Leishmania biology?

Paul W. Denny and Karunakaran Kalesh

Expert Review of Proteomics, 2020, 17, 789
DOI: 10.1080/14789450.2020.1885375

Leishmania tarentolae as a platform for the production of vaccines against viral pathogens

Marta Zimna and Ewelina Krol

npj Vaccines, 2024, 9
DOI: 10.1038/s41541-024-01005-9

Leishmania (Leishmania) amazonensis and Leishmania (Leishmania) infantum sialic acids enhance macrophage infection

Tainá Cavalcante, Antônio Moreira Marques, Mariana Medina Medeiros, Tania Carolina Reis, Daniel Quina, Bruna Cunha de Alencar, Giuseppe Palmisano and Beatriz Simonsen Stolf

Cell Biology International, 2025, 49, 357
DOI: 10.1002/cbin.12269

The endoplasmic reticulum of trypanosomatids: An unrevealed road for chemotherapy

Jana Messias Sandes and Regina Celia Bressan Queiroz de Figueiredo

Front. Cell. Infect. Microbiol., 2022, 12
DOI: 10.3389/fcimb.2022.1057774

Glycomics, Glycoproteomics, and Glycogenomics: An Inter-Taxa Evolutionary Perspective

Christopher M. West, Daniel Malzl, Alba Hykollari and Iain B.H. Wilson

Molecular & Cellular Proteomics, 2021, 20, 100024
DOI: 10.1074/mcp.R120.002263

Quantitative proteomic analysis reveals differential modulation of crucial stage specific proteins during promastigote to amastigote differentiation in Leishmania donovani

Chinmayee Bar Routaray, Vaibhavee Choudhari, Divya Prakash, Rajendra Patil, Surabhi Jagtap, Shakuntala Bai, Mahesh J. Kulkarni, Suresh V. Kuchipudi and Kalpana Pai

J Proteins Proteom, 2022, 13, 17
DOI: 10.1007/s42485-021-00080-z

Genomic reconstruction and features of glycosylation pathways in the apicomplexan Cryptosporidium parasites

Dongqiang Wang, Chenchen Wang and Guan Zhu

Front. Mol. Biosci., 2022, 9
DOI: 10.3389/fmolb.2022.1051072

The Role of Sialic Acids in the Establishment of Infections by Pathogens, With Special Focus on Leishmania

Tainá Cavalcante, Mariana Medina Medeiros, Simon Ngao Mule, Giuseppe Palmisano and Beatriz Simonsen Stolf

Front. Cell. Infect. Microbiol., 2021, 11
DOI: 10.3389/fcimb.2021.671913

Leishmania mexicana Lipophosphoglycan Activates Dermal γδ T Cells with Participation of TLR2

Nadia Soto-Olguín, Jaime Zamora-Chimal, José Delgado-Domínguez and Ingeborg Becker

Acta Parasit., 2023, 68, 122
DOI: 10.1007/s11686-022-00639-w

Comparative proteomic analysis of Leishmania parasites isolated from visceral and cutaneous leishmaniasis patients

Melike Dinç, Talat Yalçın, İbrahim Çavuş and Ahmet Özbilgin

Parasitology, 2022, 149, 298
DOI: 10.1017/S0031182021001967

Design of a stabilized non-glycosylated Pfs48/45 antigen enables a potent malaria transmission-blocking nanoparticle vaccine

Thayne H. Dickey, Richi Gupta, Holly McAleese, Tarik Ouahes, Sachy Orr-Gonzalez, Rui Ma, Olga Muratova, Nichole D. Salinas, Jen C. C. Hume, Lynn E. Lambert, Patrick E. Duffy and Niraj H. Tolia

npj Vaccines, 2023, 8
DOI: 10.1038/s41541-023-00619-9

A Human Monoclonal Antibody Targeting α-Gal Ameliorates Experimental Cutaneous Leishmaniasis

Hyeseon Cho, Andrea Paun, Youngsil Seo, Sang Hun Lee, Maria Traver, Ming Zhao, Jeff Skinner, Joshua Tan, David L Sacks and Peter D Crompton

The Journal of Infectious Diseases, 2025
DOI: 10.1093/infdis/jiaf350

Experimental structure based drug design (SBDD) applications for anti‐leishmanial drugs: A paradigm shift?

Miguel Marín, Marta López, Laura Gallego‐Yerga, Raquel Álvarez and Rafael Peláez

Medicinal Research Reviews, 2024, 44, 1055
DOI: 10.1002/med.22005